Lipoprotein(a) in Cardiovascular Disease Prevention: Current and Emerging Therapeutic Approaches
Observational research and post-hoc analyses suggest that aspirin use may be associated with lower ASCVD risk among individuals with elevated Lp(a), supporting an individualized, shared decision-making approach that considers bleeding risk, overall cardiovascular risk profile, and additional markers of cardiovascular r...